Honz Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	59.75	113.53	145.09	270.11	258.99
Cash & Short-Term Investments	59.75	113.53	145.09	270.11	258.99
Cash Growth	-47.37%	-21.75%	-46.28%	4.29%	-0.02%
Accounts Receivable	44.16	69.06	139.63	73.14	153.16
Other Receivables	11.63	25.92	39.26	52.59	66.3
Receivables	55.79	94.99	178.89	125.73	219.45
Inventory	160.12	187.33	236.43	170.4	197.87
Prepaid Expenses	-	0.38	0.43	-	-
Other Current Assets	28.82	46.85	48.51	104.22	43.59
Total Current Assets	304.48	443.07	609.35	670.46	719.9
Property, Plant & Equipment	715.17	1,022	987.29	950.53	989.88
Long-Term Investments	4.97	4.97	5.3	5.95	10.98
Goodwill	8.3	13.5	20.05	18.89	18.89
Other Intangible Assets	63.71	139.86	160.33	167.55	202.68
Long-Term Deferred Tax Assets	70.74	50.65	42.3	47.9	25.94
Long-Term Deferred Charges	55.87	77.87	81.02	75.21	72.86
Other Long-Term Assets	567.76	223.65	259.98	351.98	417.66
Total Assets	1,791	1,976	2,166	2,288	2,459
Accounts Payable	52.71	66.26	78.02	57.4	112.33
Accrued Expenses	8.59	39.74	44.29	43.8	30.47
Short-Term Debt	166.05	171.08	139.89	133.22	148.5
Current Portion of Long-Term Debt	81.17	110.51	36.77	107.05	100.78
Current Portion of Leases	-	0.46	-	-	-
Current Income Taxes Payable	15.62	3.03	16.27	3.77	4.16
Current Unearned Revenue	24.53	42.21	10.79	95.66	26.1
Other Current Liabilities	234.82	62.39	54.56	63.61	62.59
Total Current Liabilities	583.49	495.68	380.59	504.51	484.92
Long-Term Debt	181.82	210	324.98	342.85	343.52
Long-Term Leases	17.66	18.65	-	-	-
Long-Term Unearned Revenue	53.89	51.63	48.18	51	35.61
Long-Term Deferred Tax Liabilities	32.93	34.58	33.86	34.6	41.09
Total Liabilities	869.79	810.53	787.6	932.96	905.14
Common Stock	455.12	455.12	450	450	450
Additional Paid-In Capital	842.99	842.99	836.49	818.96	818.96
Retained Earnings	-464.47	-209.93	6.28	-5.25	182.34
Comprehensive Income & Other	66.07	51.73	51.98	52.47	52.65
Total Common Equity	899.71	1,140	1,345	1,316	1,504
Minority Interest	21.51	25.4	33.26	39.33	49.69
Shareholders' Equity	921.22	1,165	1,378	1,356	1,554
Total Liabilities & Equity	1,791	1,976	2,166	2,288	2,459
Total Debt	446.69	510.7	501.64	583.12	592.8
Net Cash (Debt)	-386.94	-397.17	-356.55	-313.01	-333.8
Net Cash Per Share	-0.85	-0.87	-0.79	-0.70	-0.74
Filing Date Shares Outstanding	455.15	455.12	450	450	450
Total Common Shares Outstanding	455.15	455.12	450	450	450
Working Capital	-279.01	-52.61	228.76	165.95	234.98
Book Value Per Share	1.98	2.50	2.99	2.92	3.34
Tangible Book Value	827.7	986.56	1,164	1,130	1,282
Tangible Book Value Per Share	1.82	2.17	2.59	2.51	2.85
Buildings	-	1,054	872.16	860.84	362.09
Machinery	-	398.28	383.47	381.58	289.25
Construction In Progress	-	12.03	145.62	59.59	659.28

Source: S&P Global Market Intelligence. Standard template. Financial Sources.